New CONSORT guidelines improve reporting transparency and standardization for randomized controlled trials, indicating better research quality.
Randomized controlled trials (RCTs) are considered gold standard study designs. With increasing knowledge and experience, the requirements for designing, conduct and reporting of RCTs is becoming more demanding. The Consolidated Standards of Reporting Trials (CONSORT) has been recommended as reporting guideline for the RCTs. After its first publication in 1996, there have been updates in 2001 and 2010. After almost 15 years of last update, recently revised CONSORT-2025 guideline has been published. Interestingly, the Standard Protocol Items: Recommendations for Interventional Trials guideline first published in 2013 has also undergone revision. The wording of these two guidelines has been harmonized. In this article, we have discussed important updates in the CONSORT 2025 checklist.
No takes yet. Share an insight, caveat, or question.
Moirangthem et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: